Varian to start shipping LAST units

Article

Varian Associates of Palo Alto, CA, plans to begin commercial shipments in June of its VIP-9-QR/1 digital fluoroscopy detector, which is based on the company's Large Area Sensing Technology (LAST) amorphous silicon digital detector. The company's Varian

Varian Associates of Palo Alto, CA, plans to begin commercial shipments in June of its VIP-9-QR/1 digital fluoroscopy detector, which is based on the company's Large Area Sensing Technology (LAST) amorphous silicon digital detector. The company's Varian Imaging Products subsidiary is supplying the detectors to OEMs for incorporation into complete fluoroscopy systems.

The VIP-9 detector is designed to replace image intensifier tubes in fluoroscopy systems. Image intensifiers are bulky and weigh up to 100 lb, which compares with a weight of about 15 lb for the Varian receptors. Picker International, for example, is using a Varian detector in its Venue interventional CT/x-ray suite to create more room for healthcare personnel working near patients (see story, page 3). In addition to fluoroscopy, VIP-9 supports digital radiography, and can also be used for nonmedical applications, such as nondestructive testing.

The VIP-9 detectors have not yet been cleared by the Food and Drug Administration and thus are limited to investigational use in medical applications. Varian will sell the detectors to OEMs at a list price of $98,000.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.